Post-/pre-lymphodepleting chemotherapy serum IL-15 ratio in patients treated with high dose (3600 mg/m
Serum IL-15 concentration increased in post-LD versus pre-LD samples, and there was no difference in IL-15 concentrations between the two LD regimens in patients treated in Group 3/Expansion (median of ‘high’ LD 18.25 (
